ATE220545T1 - Fentanyl enthaltendes transdermal-pflaster - Google Patents

Fentanyl enthaltendes transdermal-pflaster

Info

Publication number
ATE220545T1
ATE220545T1 AT97918413T AT97918413T ATE220545T1 AT E220545 T1 ATE220545 T1 AT E220545T1 AT 97918413 T AT97918413 T AT 97918413T AT 97918413 T AT97918413 T AT 97918413T AT E220545 T1 ATE220545 T1 AT E220545T1
Authority
AT
Austria
Prior art keywords
transdermal patch
patch containing
containing fentanyl
fentanyl
transdermal
Prior art date
Application number
AT97918413T
Other languages
English (en)
Inventor
Hideharu Chono
Takaaki Terahara
Tatsuaki Suzuki
Naruhito Higo
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE220545T1 publication Critical patent/ATE220545T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97918413T 1996-05-13 1997-05-13 Fentanyl enthaltendes transdermal-pflaster ATE220545T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14221096 1996-05-13
PCT/JP1997/001595 WO1997042952A1 (fr) 1996-05-13 1997-05-13 Preparation en ruban percutanee contenant du fentanyl

Publications (1)

Publication Number Publication Date
ATE220545T1 true ATE220545T1 (de) 2002-08-15

Family

ID=15309966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918413T ATE220545T1 (de) 1996-05-13 1997-05-13 Fentanyl enthaltendes transdermal-pflaster

Country Status (21)

Country Link
US (1) US6139866A (de)
EP (1) EP0842662B1 (de)
KR (1) KR100486705B1 (de)
CN (1) CN1119997C (de)
AR (1) AR007090A1 (de)
AT (1) ATE220545T1 (de)
AU (1) AU734081B2 (de)
BR (1) BR9706591A (de)
CA (1) CA2226834A1 (de)
DE (1) DE69713989T2 (de)
DK (1) DK0842662T3 (de)
ES (1) ES2176730T3 (de)
HK (1) HK1009746A1 (de)
ID (1) ID16894A (de)
NO (1) NO316868B1 (de)
PL (1) PL188205B1 (de)
PT (1) PT842662E (de)
RU (1) RU2194496C2 (de)
TW (1) TW411277B (de)
WO (1) WO1997042952A1 (de)
ZA (1) ZA974073B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775903B1 (fr) * 1998-03-12 2001-06-08 Lhd Lab Hygiene Dietetique Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation
CA2318047A1 (en) * 1998-10-05 2000-04-13 Yutoku Pharmaceutical Ind. Co., Ltd. Tape material for transcutaneous absorption
AU3932600A (en) * 1999-04-01 2000-10-23 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
KR100674108B1 (ko) * 1999-04-13 2007-01-26 히사미쓰 세이야꾸 가부시키가이샤 경피흡수형 제제
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
CA2393762A1 (en) * 1999-12-16 2001-06-21 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
KR100940245B1 (ko) 2000-09-19 2010-02-04 내쇼날 스타치 앤드 케미칼 인베스트멘트 홀딩 코포레이션 경피 약물 전달 시스템에 유용한 비반응성 접착제
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE20221397U1 (de) 2001-03-16 2005-10-20 Alza Corp., Mountain View Transdermal-Pflaster zum Verabreichen von Fentanyl
DE20221841U1 (de) * 2001-03-16 2008-05-21 Alza Corp., Mountain View Transdermal-Pflaster zum Verabreichen von Fentanyl
NZ531789A (en) * 2001-08-17 2006-01-27 Lavipharm Lab Inc A medical device from which analgesic drugs are delivered from a drug reservoir controlled by plasticizers and adhesive matrix material
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
KR100844312B1 (ko) * 2001-09-06 2008-07-07 노사케미컬(주) 펜타닐 경피 투여 제제
US20030059450A1 (en) 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
CN1571664A (zh) * 2001-10-17 2005-01-26 久光制药株式会社 经皮吸收型制剂
DK1480625T3 (da) * 2002-03-06 2008-10-27 Hexal Ag Transdermalt system med fentanyl
TW200404581A (en) 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097008A2 (en) * 2002-05-15 2003-11-27 Thalas Group Incorporated Transdermal delivery device for the administration of fentanyl
JP4199485B2 (ja) * 2002-06-07 2008-12-17 久光製薬株式会社 貼付剤
US7785622B2 (en) * 2002-09-13 2010-08-31 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch for fentanyl administration
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JP5137286B2 (ja) 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
EP1638398A1 (de) * 2003-06-17 2006-03-29 Henkel Kommanditgesellschaft auf Aktien Hemmung der asexuellen vermehrung von pilzen durch eugenol und/oder dessen derivate
JP4468669B2 (ja) * 2003-09-22 2010-05-26 久光製薬株式会社 低刺激性貼付剤
WO2005044243A2 (en) * 2003-10-30 2005-05-19 Alza Corporation Transdermal analgesic systems having reduced abuse potential
DE102004028284A1 (de) * 2004-06-11 2006-01-05 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin
JP4824963B2 (ja) 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
JP2008517934A (ja) 2004-10-21 2008-05-29 デュレクト コーポレーション 経皮デリバリーシステム
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP1661560B1 (de) * 2004-11-22 2008-11-05 Hisamitsu Pharmaceutical Co., Inc. Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
WO2007035939A2 (en) 2005-09-23 2007-03-29 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
US20070104771A1 (en) * 2005-09-23 2007-05-10 Jay Audett Transdermal galantamine delivery system
US20070098772A1 (en) * 2005-09-23 2007-05-03 Westcott Tyler D Transdermal norelgestromin delivery system
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
MY149142A (en) 2006-08-04 2013-07-15 Hisamitsu Pharmaceutical Co Adhesive preparation
US20100047327A1 (en) * 2007-01-31 2010-02-25 Tetsuji Kuwahara Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
CN101801452B (zh) 2007-08-06 2014-10-22 阿勒根公司 用于去氨加压素药物给送的设备
EP2207507B1 (de) 2007-10-15 2018-11-21 Alza Corporation Einmal tägliche transdermale ersatz-verabreichung von fentanyl
KR20160027258A (ko) * 2008-01-28 2016-03-09 데이고꾸세이약꾸가부시끼가이샤 펜타닐 함유 외용 패치
RU2474418C2 (ru) * 2008-01-31 2013-02-10 Хисамицу Фармасьютикал Ко., Инк. Лейкопластырь
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
SI3225249T1 (sl) 2008-05-21 2019-02-28 Ferring B.V. Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
JP5927506B2 (ja) 2010-04-13 2016-06-01 レルマダ セラピューティクス、インク． １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
EP2462927A1 (de) * 2010-12-03 2012-06-13 Hexal AG Transdermales therapeutisches System mit Fentanyl
KR20120107153A (ko) * 2011-03-15 2012-10-02 아이큐어 주식회사 펜타닐 경피 패치제
WO2012142452A2 (en) 2011-04-13 2012-10-18 Biosafe Technologies, Inc. Cleaning, insecticide, insect repellant, glue solvent and anti-irritation composition
EP2759294B1 (de) * 2011-09-22 2017-11-01 Samyang Biopharmaceuticals Corporation Perkutan absorbierbares präparat mit fentanyl und einem homolog davon
PT2878299T (pt) * 2012-07-26 2018-07-06 Hisamitsu Pharmaceutical Co Emplastro adesivo
CN103655523A (zh) * 2013-12-24 2014-03-26 南京艾德凯腾生物医药有限责任公司 他喷他多组合物
ES2785549T3 (es) 2014-07-18 2020-10-07 Buzzz Pharmaceuticals Ltd Parche transdérmico de oximorfona
EP3233081B1 (de) * 2014-12-19 2021-09-22 Kindeva Drug Delivery L.P. Transdermale arzneimittelverabreichungsvorrichtung enthaltend fentanyl
ES2805342T3 (es) * 2015-10-26 2021-02-11 Hisamitsu Pharmaceutical Co Parche cutáneo adhesivo
FR3062572B1 (fr) * 2017-02-03 2020-05-29 B. Braun Medical Composition adhesive et element de fixation sur la peau humaine
WO2021014184A1 (en) * 2019-07-19 2021-01-28 Hikma Pharmaceuticals International Limited Ready-to-administer fentanyl formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3243564B2 (ja) * 1990-08-20 2002-01-07 リードケミカル株式会社 外用貼付剤
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
JPH0640947A (ja) * 1992-07-28 1994-02-15 T T S Gijutsu Kenkyusho:Kk 経皮吸収製剤用組成物および経皮吸収製剤
RU2136319C1 (ru) * 1993-12-23 1999-09-10 Джонсон энд Джонсон Медикал, Инк. Биоабсорбируемое хирургическое гемостатическое средство и способ его получения (варианты)
AU2266995A (en) * 1994-04-21 1995-11-16 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤

Also Published As

Publication number Publication date
KR19990028787A (ko) 1999-04-15
WO1997042952A1 (fr) 1997-11-20
CN1193275A (zh) 1998-09-16
ZA974073B (en) 1997-12-09
DE69713989D1 (de) 2002-08-22
TW411277B (en) 2000-11-11
EP0842662A4 (de) 1999-02-24
CA2226834A1 (en) 1997-11-20
KR100486705B1 (ko) 2005-06-16
AU2652597A (en) 1997-12-05
BR9706591A (pt) 1999-12-28
NO980126L (no) 1998-03-10
RU2194496C2 (ru) 2002-12-20
PL324492A1 (en) 1998-05-25
EP0842662A1 (de) 1998-05-20
NO980126D0 (no) 1998-01-12
PL188205B1 (pl) 2004-12-31
HK1009746A1 (en) 1999-09-03
PT842662E (pt) 2002-10-31
EP0842662B1 (de) 2002-07-17
ID16894A (id) 1997-11-20
NO316868B1 (no) 2004-06-07
CN1119997C (zh) 2003-09-03
AU734081B2 (en) 2001-05-31
US6139866A (en) 2000-10-31
ES2176730T3 (es) 2002-12-01
DE69713989T2 (de) 2003-02-27
AR007090A1 (es) 1999-10-13
DK0842662T3 (da) 2002-10-07

Similar Documents

Publication Publication Date Title
ATE220545T1 (de) Fentanyl enthaltendes transdermal-pflaster
ITMI981889A0 (it) Cerotto transdermico
DE69832055D1 (de) Transdermales abgabesystem
FI99268B (fi) Kerrosmateriaali
DK199801546A (da) Forbedret fodtøj
DE69803592D1 (de) Kristallisationshemmung in transdermalen vorrichtungen
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DK0927183T3 (da) Spirocykliske metalloprotease-inhibitorer
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
IL116895A (en) Transdermal patch comprising xanomeline
DE69738825D1 (de) Felbinac enthaltendes Pflaster
HUP0000445A3 (en) Flat transdermal medicated self-adhesive patch
FI973362A (fi) Transdermaalinen formula
DE69801265D1 (de) Solevorrichtung
DE69821096D1 (de) Pflaster-zubereitungen zur transdermalen absorption
DK0968009T3 (da) Gel til sårforbinding
DK0963312T3 (da) Forankringsindretning
DE60044865D1 (de) Testen von geschütztem material
IT1293425B1 (it) Cerotto transcutaneo
FI960435A0 (fi) Lääkkeiden transdermaalisen antotapaan tarkoitettuLääkkeiden transdermaalisen antotapaan tarkoitettu koostumus koostumus
KR970003945U (ko) 다리 교정용 신발창
ATA200597A (de) Einrichtung zur diebstahlsicherung von magazinbeuten
ATE249634T1 (de) Polarisationsschicht
IT241474Y1 (it) Sottopiede per calzatura
DK0850065T3 (da) Transdermalt terapeutisk system til silatranforbindelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee